ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – PLSEBusiness Wire • 02/28/22
PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the FirmNewsfile Corp • 02/28/22
ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSENewsfile Corp • 02/27/22
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSENewsfile Corp • 02/26/22
Investor Action Alert: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/25/22
PLSE Equity Alert: ROSEN, A Top Ranked Investor Law Firm, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSENewsfile Corp • 02/24/22
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)Business Wire • 02/24/22
ALERT: Investors in Pulse Biosciences, Inc. With Substantial Losses Have Opportunity to Lead Class Action Lawsuit – PLSEBusiness Wire • 02/24/22
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSEPRNewsWire • 02/22/22
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)Business Wire • 02/22/22
Shareholder Alert: Robbins LLP Reminds Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading ShareholdersBusiness Wire • 02/21/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 02/21/22
DEADLINE: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSEPRNewsWire • 02/19/22
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 02/18/22
Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading ShareholdersBusiness Wire • 02/18/22
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSEBusiness Wire • 02/18/22
PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 02/18/22
ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSEBusiness Wire • 02/18/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) InvestorsBusiness Wire • 02/17/22
(PLSE) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Pulse Biosciences Class Action LawsuitNewsfile Corp • 02/17/22
PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.Business Wire • 02/17/22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial OfficerBusiness Wire • 02/15/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of InvestorsBusiness Wire • 02/14/22
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of InvestorsBusiness Wire • 02/14/22
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 02/14/22
